Anxiety Depression Disorder Clinical Trial
Official title:
Study on the Efficacy of Vetiver Essential Oil Aroma on Depression/Anxiety People
NCT number | NCT05024136 |
Other study ID # | CS1-20030 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | January 20, 2021 |
Est. completion date | March 2023 |
In this study, subjects with depression/anxiety inhaled the essential oil, which contained sedative, soothing, and relaxing active ingredients to stimulate the olfactory nerve. The essential oil further transmitted to the limbic system that controls emotions in the brain, and then affected the human's mood. The natural aroma can not only awaken the limbic system's memory of aroma but also reflect the subconscious area of the brain, with physiological changes (such as controlling blood pressure, breathing, heartbeat, stress changes, memory, and hormonal coordination.) This study monitors the subject's autonomic nerve parameters before and after aromatherapy to obtain the olfactory cerebral nervous system to convey the message. When the study finishes, we expected to help the subject to relax and soothe the mind.
Status | Recruiting |
Enrollment | 60 |
Est. completion date | March 2023 |
Est. primary completion date | October 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 20 Years to 65 Years |
Eligibility | Inclusion Criteria: 1. Depressed/anxious people (diagnosed as a single episode of major depression, recurrence of major depression, mild depression, panic disorder, and anxiety.) Those diagnosed with symptoms of depression, and anxiety related to stress adjustment disorder, and willing to cooperate with the study. 2. Age 20-65 years old Exclusion Criteria: 1. an alcoholic 2. Uncontrolled diabetes 3. Those who have had a stroke in the last year 4. Pregnant and lactating women 5. People with liver or heart disease 6. Arrhythmia or those with a heart rhythm regulator 7. Those whose heart has already been fitted with a cardiac catheter stent 8. Those who have used central nervous system stimulants (regardless of the length of time) 9. Those who are allergic to essential oils 10. Those who have used aromatherapy within a month 11. Subjects request to withdraw from the trial 12. The host feels unsuitable to continue the study |
Country | Name | City | State |
---|---|---|---|
Taiwan | Chung Shan Medical University | Taichung |
Lead Sponsor | Collaborator |
---|---|
Chung Shan Medical University |
Taiwan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The aromatherapy measure autonomic nerve parameter SDNN (standard deviation of all normal to normal intervals index) | one month | ||
Primary | The measure blood pressure (SBP and DBP) | values change of systolic and diastolic BPs | one month |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06406595 -
Hemispheric Asymmetries in Emotion-Cognition Interactions
|
||
Not yet recruiting |
NCT06112457 -
Anxiety and Depression Among Gendarmes Posted to French Guiana
|
||
Completed |
NCT05531929 -
Role of Anxio-depressive History on Return to Work and Sport After Rotator Cuff Surgery
|
||
Enrolling by invitation |
NCT04662021 -
Aerobic Training Versus Cognitive Behavioral Therapy in Management of Anxiety
|
N/A |